INDIAN BENCHMARK started the trading session on a mildly lower note tracking negative global clues. Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Divalproex Sodium Extended-release Tablets USP 250mg and 500mg.
FURTHER, Bharat Petroleum Corporation is planning to open an office in Singapore to expand its global reach and participate in crude oil trading. Coal India plans to form a panel of consultants which would help the PSU in acquiring, developing and operating coal mines overseas.
Trend in FII flows: The FIIs were net buyers of Rs 2977cr in the cash segment on Tuesday while the DIIs were net sellers of Rs. 99cr, as per the provisional figures released by the NSE.
FURTHER, Bharat Petroleum Corporation is planning to open an office in Singapore to expand its global reach and participate in crude oil trading. Coal India plans to form a panel of consultants which would help the PSU in acquiring, developing and operating coal mines overseas.
Trend in FII flows: The FIIs were net buyers of Rs 2977cr in the cash segment on Tuesday while the DIIs were net sellers of Rs. 99cr, as per the provisional figures released by the NSE.
For More Detail Call Us 0731-6790000,6669900
Click Here capitalstars.com
Click Here capitalstars.com
1 Comments
Thanks for sharing news on equity market with us. You are the best Stock Cash Tips Provider i have ever seen.
ReplyDelete